News

Latest News and Press Releases

We provide the latest updates, press releases, and event details about our activities and services. Stay informed about our progress and future outlook through our latest news.

  1. All post
  2. Others
  3. Press Release
  4. TSE Filings
Press Release

Abrax Japan Announces Innovative Approach to Stimulate Weight Loss and Seek FDA Approval for Lipid Disorders
Press Release

Abrax Japan and Kyushu University Graduate School concluded Joint Research Agreement
TSE Filings

Abrax Japan’s lead asset ABX was featured in an information program on the TBS network
Others

Dr. Taku Kambayashi will appear on Nippon TV series “Learn with Kazu-Laser” on June 20, 2023.
TSE Filings

Abrax Japan Announces Completion of IND-Enabling Safety Studies to Advance Lead Program towards Clinical Trials
TSE Filings

Abrax Japan Announces License Agreement with the University of Pennsylvania

Load more
LOADING...
Others

Dr. Taku Kambayashi will appear on Nippon TV series “Learn with Kazu-Laser” on June 20, 2023.
TSE Filings

Abrax Japan Announces Completion of IND-Enabling Safety Studies to Advance Lead Program towards Clinical Trials
TSE Filings

Abrax Japan Announces License Agreement with the University of Pennsylvania
TSE Filings

Dr. Kambayashi wins both competitions in STAT Madness 2022
TSE Filings

Abrax Japan announces $3 million Seed 4 financing to support clinical development of ABX-919 for atopic dermatitis
TSE Filings

Co-founder of Abrax Japan, Dr. Taku Kambayashi, publishes article in Science entitled “Thymic stromal lymphopoietin induces adipose loss through sebum hypersecretion”

Load more
LOADING...
Press Release

Abrax Japan Announces Innovative Approach to Stimulate Weight Loss and Seek FDA Approval for Lipid Disorders
Press Release

Abrax Japan and Kyushu University Graduate School concluded Joint Research Agreement
TSE Filings

Abrax Japan’s lead asset ABX was featured in an information program on the TBS network
TSE Filings

Abrax Japan Announces Completion of IND-Enabling Safety Studies to Advance Lead Program towards Clinical Trials
TSE Filings

Abrax Japan Announces License Agreement with the University of Pennsylvania
TSE Filings

Dr. Kambayashi wins both competitions in STAT Madness 2022

Load more
LOADING...
TSE Filings

Abrax Japan’s lead asset ABX was featured in an information program on the TBS network
TSE Filings

Abrax Japan Announces Completion of IND-Enabling Safety Studies to Advance Lead Program towards Clinical Trials
TSE Filings

Abrax Japan Announces License Agreement with the University of Pennsylvania
TSE Filings

Dr. Kambayashi wins both competitions in STAT Madness 2022
TSE Filings

Abrax Japan announces $3 million Seed 4 financing to support clinical development of ABX-919 for atopic dermatitis
TSE Filings

Co-founder of Abrax Japan, Dr. Taku Kambayashi, publishes article in Science entitled “Thymic stromal lymphopoietin induces adipose loss through sebum hypersecretion”

Load more
LOADING...